Health
Study elucidates the mode of action of SGLT2 inhibitors in diabetes – News-Medical.Net
Although SGLT-2 inhibitors are central to the treatment of diabetes, their exact mode of action was hitherto unknown.
Although SGLT-2 inhibitors are central to the treatment of diabetes, their exact mode of action was hitherto unknown. In a study conducted by a research group led by Peter Wolf, Martin Krssak and Michael Krebs from MedUni Vienna’s Department of Medicine III, magnetic resonance spectroscopy (MRS) was used to show that there is a direct correlation between the elimination of glucose via the kidneys and new glucose production in the liver.
A single dose of the SGLT-2 inhibitor dapagliflozin gives rise…
-
Business23 hours ago2 strong ASX ETFs to buy and hold forever
-
Noosa News22 hours agoAndrew Burow: Link to alleged attacker uncovered in suspected murder of Kelvin Grove father
-
Business22 hours agoTop broker gives its verdict on Coles shares after 25% rise
-
Business24 hours agoIs Nvidia’s increasing reliance on “Customer A” and “Customer B” a red flag for the AI growth stock?